Schedule 13D ownership disclosure

CARDLYTICS INC

Common Stock, par value $0.0001 · CUSIP: 14161W105

Event date: 2025-08-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CAS Investment Partners, LLCReported CIK 0001697591

    Shares: 5,198,067.00 · Class: 9.8%

  • SOSIN MASTER, LP

    Shares: 3,198,584.00 · Class: 6.0%

  • CSWR PARTNERS, LP

    Shares: 1,999,483.00 · Class: 3.8%

  • SOSIN LLC

    Shares: 5,198,067.00 · Class: 9.8%

  • SOSIN CLIFFORDReported CIK 0001697919

    Shares: 5,198,067.00 · Class: 9.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002345
Form type
SCHEDULE 13D/A
Filer
CAS Investment Partners, LLC
CIK
CIK 1697591
Filed
Aug 20, 2025
Reporting period
Aug 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub